Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3509157019 | Naphazoline nitrate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3509158012 | Naphazoline nitrate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naphazoline nitrate (substance) | Is a | Naphazoline (substance) | false | Inferred relationship | Some | ||
| Naphazoline nitrate (substance) | Has disposition (attribute) | Alpha adrenergic receptor agonist (disposition) | true | Inferred relationship | Some | ||
| Naphazoline nitrate (substance) | Is a | Alpha adrenergic receptor agonist | true | Inferred relationship | Some | ||
| Naphazoline nitrate (substance) | Is a | Imidazole | true | Inferred relationship | Some | ||
| Naphazoline nitrate (substance) | Is a | Vasoconstrictor | false | Inferred relationship | Some | ||
| Naphazoline nitrate (substance) | Is modification of (attribute) | Naphazoline (substance) | true | Inferred relationship | Some | ||
| Naphazoline nitrate (substance) | Is a | Adrenergic receptor agonist | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has precise active ingredient | True | Naphazoline nitrate (substance) | Inferred relationship | Some | 2 |
| Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) | Has basis of strength substance (attribute) | True | Naphazoline nitrate (substance) | Inferred relationship | Some | 2 |
This concept is not in any reference sets
FHIR